{"id":14734,"date":"2012-03-30T01:30:00","date_gmt":"2012-03-29T23:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/big-pharma-40-mln-in-lobbying-ue\/"},"modified":"2012-03-30T01:30:00","modified_gmt":"2012-03-29T23:30:00","slug":"big-pharma-40-mln-in-lobbying-ue","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/big-pharma-40-mln-in-lobbying-ue\/","title":{"rendered":"Big Pharma, 40 million in EU lobbying"},"content":{"rendered":"<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: &quot;Book Antiqua&quot;,&quot;serif&quot;; color: #212120; font-size: 12pt; mso-bidi-font-family: 'Book Antiqua'\">Big Pharma spends 40 million euros a year on its lobbying activities in the European Union. It is one of the main findings of a report produced by the Corporate Europe Observatory and Health Action International Europe, in which the statements of pharmaceutical companies and their representatives in the European lobby transparency register were examined. <\/p>\n<p><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: &quot;Book Antiqua&quot;,&quot;serif&quot;; color: #212120; font-size: 12pt; mso-bidi-font-family: 'Book Antiqua'\">The estimate clearly exceeds that of 3.4 million euros spent on lobbying by non-governmental organizations in the public health sector. The document therefore points out that &quot;with the immense disparity between the resources of public interest groups and industrial lobbies, it becomes increasingly difficult to level the political playing field&quot;. Furthermore, it should be noted that many industries do not declare their lobbying activities: registration in the transparency register is in fact voluntary. But experts put forward an estimate of the &#039;submerged&#039; resources reserved for this purpose: they could exceed 91 million euros annually, a figure more in line with that declared by the companies themselves in the United States. It is also estimated that around 220 lobbyists are active in the European pharmaceutical sector. Health Action International Europe project officer Katrina Perehudoff points out that the pharmaceutical industry &quot;has a significant presence in Brussels and is clearly spending a significant amount of money on lobbying. <\/p>\n<p><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: &quot;Book Antiqua&quot;,&quot;serif&quot;; color: #212120; font-size: 12pt; mso-bidi-font-family: 'Book Antiqua'\">However, now we only have a partial picture of the total picture&quot;. For Olivier Hoedeman, of the Corporate Europe Observatory, &quot;there is an urgent need to strengthen the European transparency register and to make registration compulsory<\/span><span style=\"font-family: &quot;Book Antiqua&quot;,&quot;serif&quot;; color: #212120; font-size: 9pt; mso-bidi-font-family: 'Book Antiqua'\">&quot;. <\/p>\n<p><\/span><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><em style=\"mso-bidi-font-style: normal\"><span style=\"line-height: 115%; font-family: &quot;Times Roman Bold Italic&quot;; color: #212120; font-size: 9pt; mso-bidi-font-family: 'Times Roman Bold Italic'\"><font face=\"Calibri\">Barbara Di Chiara \u2013 March 30, 2012 \u2013 PharmaKronos<\/font><\/span><\/em><em style=\"mso-bidi-font-style: normal\"><span style=\"line-height: 115%; font-size: 9pt\"><\/p>\n<p><\/span><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Big Pharma spende 40 milioni di euro l&#8217;anno per le proprie attivit&agrave; di lobbying nell&#8217;Unione europea. E&#8217; uno dei risultati principali di un rapporto realizzato da Corporate Europe Observatory e Health Action International Europe, in cui sono state esaminate le dichiarazioni delle aziende farmaceutiche e dei loro rappresentanti nel registro europeo di trasparenza delle lobby. &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14734","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14734"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14734\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14734"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}